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Abstract
Background: PABA/NO is a diazeniumdiolate that acts as a direct nitrogen monoxide (NO) donor and is in development as
an anticancer drug. Its mechanism of action and effect on cells is not yet fully understood.
Methodology/Principal Findings: We used HPLC and mass spectrometry to identify a primary nitroaromatic glutathione
metabolite of PABA/NO and used fluorescent assays to characterize drug effects on calcium and NO homeostasis, relating
these to endothelial nitric oxide synthase (eNOS) activity. Unexpectedly, the glutathione conjugate was found to be a
competitive inhibitor of sarcoplasmic/endoplasmic reticulum Ca
2+-ATPase (SERCA) presumably at the same site as
thapsigargin, increasing intracellular Ca
2+ release and causing auto-regulation of eNOS through S-glutathionylation.
Conclusions/Significance: The initial direct release of NO after PABA/NO was followed by an eNOS-mediated generation of
NO as a consequence of drug-induced increase in Ca
2+ flux and calmodulin (CaM) activation. PABA/NO has a unique dual
mechanism of action with direct intracellular NO generation combined with metabolite driven regulation of eNOS
activation.
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Introduction
Endogenous NO is a potent signaling molecule influencing
numerous physiological functions. Cellular levels of NO are
controlled by several isoforms of nitric oxide synthase (NOS):
neuronal (nNOS, NOS1), inducible (iNOS, NOS2), and endothe-
lial (eNOS, NOS3). Each isoform is a product of a distinct gene
[1]. Both, nNOS and eNOS, are constitutively expressed and
primarily isolated from neurons and endothelial cells, respectively.
NO generation by these enzymes is controlled by the elevation of
intracellular Ca
2+ and the consequent activation of calmodulin
(CaM). iNOS is not constitutively expressed and is not calcium-
dependent. Despite its physiological functions, high levels of
intracellular NO are toxic and provide a translational opportunity
to induce cytotoxicity in tumor cells [2]. This led to the
development of a class of anticancer agents selectively activated
in tumors by glutathione S-transferase pi (GSTP) to liberate toxic
levels of NO [3]. The contribution of NOS to the cytotoxic effects
of these agents has not been explored and is the focus of these
studies.
Para-amino-benzoic acid (PABA) has been tested as a
radioprotector [4] and PABA/NO (O
2-{2,4-dinitro-5-[4-(N-
methylamino)benzoyloxy]phenyl}1-(N,N-dimethylamino)diazen-
1-ium-1,2-diolate) is an anticancer prodrug with antitumor activity
in vitro and in human ovarian cancer xenograft mouse models
[5,6]. PABA/NO has N-methyl-p-aminobenzoic acid bound via
its carboxyl oxygen as a 5-substituent of the 2,4-dinitrophenyl ring
[3]. PABA/NO belongs to the O2-aryl diazeniumdiolates
(O2ADs) — electrophiles shown to transfer their aryl groups to
the attacking nucleophiles with a simultaneous production of ions
that spontaneously release NO at a physiological pH [7]. In the
presence of glutathione (GSH), PABA/NO becomes activated
(spontaneously or through the glutathione S-transferase pi
(GSTP)-mediated catalysis) and results in the formation of a
Meisenheimer-complex intermediate, where subsequently the
leaving group of the reaction generates two moles of NO [7]. As
a consequence, elevated NO levels lead to cytotoxic effects by
forming reactive nitrogen/oxygen intermediates. PABA/NO-
induced nitrosative stress results in limited levels of protein
nitrosylation/nitration and high levels of S-glutathionylation, and
these are associated with cytotoxicity in human promyelocytic
leukemia (HL60) cells [6].
S-glutathionylation is an oxidative post-translational modifica-
tion of low pKa cysteine residues in target proteins. The forward
rate of the S-glutathionylation reaction is regulated by GSTP
[8,9,10,11], while the reverse rate is regulated by a number of
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and sulfiredoxin [13,14]. Proteins affected by S-glutathionylation
include ion channels such as a Ca
2+-release/ryanodine receptor
channel (RyR) and a phosphorylation/ATP-dependent chloride
channel that modulates salt and water transport in the lung and
gut [15,16,17]. Regulatory effects of S-glutathionylation have also
been described for the SERCA, [18]. Following peroxynitrite
treatment, SERCA is S-glutathionylated at Cys674, both in vitro
and in intact cells or arteries [18,19]. This modification activates
SERCA, resulting in a decrease of cytosolic Ca
2+.
Alterations in intracellular Ca
2+ can be associated with its influx
from the extracellular space, as well as by its release from
intracellular stores (ER, SR, mitochondria etc). Increased intracel-
lular concentrations of free Ca
2+ influence a number of cellular
processes that include proliferation, contractility and secretion
[20,21]. Plasma membranes have an initially low permeability to
Ca
2+, with active Ca
2+ uptake occurring against an electrochemical
gradient. This process is mediated by Ca
2+ -ATPases contained in
both plasma and organelle membranes of intracellular Ca
2+ stores.
The overall result is that intracellular Ca
2+ is maintained at low
levels.
We have focused the present study on understanding how
PABA/NO metabolism may influence NO homeostasis both
directly and indirectly through altering intracellular Ca
2+ and
NOS activity.
Results
Kinetic analysis of PABA/NO-derived NO generation in
HL60 cells as compare to that of the short- and long-lived
standard NO generators
Figure 1 shows the intracellular generation of NO in HL60 cells
exposed to either PABA/NO or diethylenetriamine/nitric oxide
adduct (DETA/NO). The kinetics of NO release after PABA/NO
are shown in Fig. 1, panel A. After an early lag phase, the curve
becomes S shaped. This becomes linear (Fig. 1, panel A) after
pretreatment of cells with the NOS inhibitor - N
v-nitro-L-arginine
methyl ester (L-NAME, [22]). At equimolar doses, release of NO
from DETA/NO was linear, but lower than PABA/NO, and from
diethyleneamine NONOate (DEA NONO-ate) initially was linear,
but higher than PABA/NO (Fig. 1, panel A), and both were
insensitive to L-NAME treatment (data not shown). PABA-NO-
mediated NO generation both in vitro and in vivo coincided with
generation of a fluorescent product (Fig. 1, panel B). The kinetics
of NO generation shortly (,300 s) after PABA/NO reflected a
,2:1 molar ratio to stable fluorescent product (Fig. 1, panel C).
After longer incubations (Fig. 1, panel D) a ,4:1 molar ratio
indicated an accelerated NO production compared to levels
expected merely from PABA/NO decomposition.
Comparative analysis of Ca
2+ and NO fluxes initiated by
PABA/NO addition to HL60 cells and proportionality of
NO generation to eNOS expression
The observed lag phase implied a response to an accumulation
of signaling molecule. Thus, Fig. 2 shows the time- and dose-
dependent calcium mobilization in HL60 cells. Treatment of
HL60 cells with 25 mM PABA/NO resulted in a time-dependent
bell-shaped increase of intracellular Ca
2+ with levels increasing
proportionally with drug-treatment. Thapsigargin (ThG) mobilizes
Ca
2+ through the inhibition of SERCA and was used as a positive
control. The Ca
2+ increases initiated by ThG (Fig. 2, panel A)
were similar to those for PABA/NO. Pre-incubation of HL60 cells
with PABA/NO (15 mM) substantially diminished those increases
in intracellular Ca
2+ caused by the addition of 20 nM ThG (Fig. 2,
panel A). Titration of HL60 cells with an increased amount of
PABA/NO gradually decreased ThG-mediated Ca
2+ fluxes with
an IC50 of ,3 mM (Fig. 2, panel B). Similar titration of cells with
purified homogeneous PABA/NO-GSH adduct (MW,622 Da)
was close to that of PABA/NO (IC50 ,5 mM; Fig. 2, panel B).
These results are consistent with an intracellular store acting as a
source of the released Ca
2+. Calibration of Fluo-3 fluorescence
emission [23] permitted calculation of an actual intracellular Ca
2+
concentrations in HL60 cells of 110612.0 nM. Prior chelation of
extracellular Ca
2+ with EGTA (5 mM) minimally affected the
PABA/NO-initiated increases in intracellular Ca
2+, while chelat-
ing intracellular Ca
2+ with BAPTA (6 mM) substantially decreased
the PABA/NO-mediated mobilization of Ca
2+ (Fig. 2, panel C)
similar to that for the ThG-mediated Ca
2+-fluxes (data not shown).
Interestingly, treatment of HL60 cells with PABA or DEA
NONO-ate (instead of PABA/NO) did not have any significant
effect on Ca
2+ fluxes (Fig. 2, panels A and C). These results implied
that PABA/NO-GSH adduct (MW ,622 Da) is most likely
responsible for this specific effect. Plotting the temporal events of
Ca
2+ mobilization and NO generation in HL60 cells after PABA/
NO treatment showed that Ca
2+ increases precede those for NO
(Fig. 2, panel D), suggesting Ca
2+-mediated the NO generation.
Although ,8-fold higher, a similar pattern of NO generation was
also seen in human dermal microvascular endothelial cells
(HDMVEC, Fig. 2, panel D).
These data suggested a role for Ca
2+-dependent NO generation
following PABA/NO addition. In HL60 cells, NO homeostasis is
controlled by the expression of both iNOS (NOS2, calcium
independent, [24]) and eNOS (NOS3, calcium-dependent). Based
on immunoblot analysis, nNOS (NOS1) was absent from HL60
cells (data not shown).
siRNA-mediated ‘‘knock down’’ of eNOS in HL60 cells
To determine how PABA/NO treatment might influence NO
homeostasis, we transiently suppressed eNOS expression with
siRNA. To monitor the transfection efficiency, we used FITC-
labeled siRNA. Our results show that the transfection efficiency of
eNOS siRNA in HL60 cells was ,80% (Fig. 3, panel A).
Suppression of eNOS did not alter cell viability (Fig. 3, panel B),
but resulted in ,80% decrease of eNOS protein expression (Fig. 3,
panel C-D). By comparative immunostaining, the level of eNOS
was found to be ,10-fold higher in HDMVEC when compared to
HL60 cells (Fig. 3 panel E).
Effect of eNOS ‘‘knock down’’ in HL60 cells on the PABA/
NO-mediated NO and Ca
2+ fluxes
Basal levels of NO in the eNOS siRNA transfected cells
(TReNOS
2/2) were decreased by ,50%, (Fig. 4, panel A). The
siRNA depletion of eNOS levels did not impact the intracellular
Ca
2+ response to PABA/NO or ThG (Fig. 4, panel C), which
remained similar to that of the control cells (Fig. 2, panel A). NO
generation following either 0–50 mM PABA/NO or 0–1,000 nM
ThG treatments was statistically different with the EC50 values of
,5 mM and ,85 nM, respectively. PABA did not affect NO
generation in HL60 cells (Fig. 4, panel B). These data are
compatible with an ,50% effect of Ca
2+-dependent NO
generation in total response of HL60 cells to PABA/NO. The
eNOS suppression in HL60 cells was accompanied by a slowing of
cell growth rate (Fig. 4, panel D), indicating a link between NO
metabolism and the cell proliferation pathways.
Nitric Oxide/Ca
2+ Homeostasis
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CaM is a key regulator in eNOS activation. HL60 and
TReNOS
2/2 cells were treated with the CaM inhibitor W-7
prior to PABA/NO treatment. The addition of W-7 to HL60 cells
resulted in ,50% decrease in NO levels when compared to the
untreated cells (Fig. 5, panel A). In contrast, W-7 to did not affect
intracellular NO levels in TReNOS
2/2 cells (Fig. 5, panel A).
Inhibition of CaM in HL60 cells substantially diminished the NO
response similar to that in TReNOS
2/2 cells following PABA/
NO addition (Fig. 5, panel B). These data are compatible with a
partial eNOS-mediated NO response of HL60 cells to PABA/NO
in addition to known spontaneous and/or GSTP-mediated GSH
nucleophilic attack on this prodrug [5].
Figure 1. PABA/NO-induced NO and fluorescent derivative generation kinetics in HL60 cells. A) PABA/NO (25 mM) addition to HL60 cells
corresponds with an S-shaped generation of NO, becoming linear after cells are pretreated with 50 nM L-NAME for 30 min prior to PABA/NO (100 and
200 nM of L-NAME addition did not show any difference). DETA/NO and DEA NONOate (25 mM) addition to HL60 cells result in linear NO generation
kinetics. B) Emission and excitation spectra of a purified fluorescent nitro-aromatic product (MW 622 Da) C) and D) Short and long exposure of HL60
cells to 25 mM PABA/NO produces linear kinetics for the fluorescent nitro-aromatic product (MW 622 Da) and S-shaped kinetics for NO generation.
Data are: trace smoothed with Sigma Plot 10 software (panel A) and original traces (Panels B, C and D) representative of three independent
experiments. Arrows indicate addition of drug.
doi:10.1371/journal.pone.0014151.g001
Nitric Oxide/Ca
2+ Homeostasis
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HL60 cells
To estimate basal levels of NO in HL60 cells, quantitative
fluorescence measurements of these cells were compared with
human umbilical vein endothelial cells (HUVEC), which contain
,20 nM NO (see Materials and Methods). Our calculations
estimated NO concentrations at ,1.2 nM in HL60 cells and
,14.0 nM in HDMVEC (Table 1). Addition of PABA/NO
(5 mM) caused increases of NO levels to ,2.6 nM in HL60 and to
,182.0 nM in HDMVEC.
Effect of PABA/NO treatment on eNOS glutathionylation
in HL60 and HDMVE cells
PABA/NO- mediated NO generation in HL60 cells became
linear after an incubation for ,600 s (Fig. 1, panel A). This could
be associated with an auto-regulation of eNOS by NO in HL60
Figure 2. PABA/NO treatment of HL60 cells results in temporal and dose-dependent increases in intracellular Ca
2+. A) Time-
dependent increases were assessed following treatment with 20 nM ThG; 25 mM PABA/NO; 25 mM PABA; 20 nM ThG after pretreatment with PABA/
NO (15 mM, 30 min); 25 mM DEA NONOate B) Competitive inhibition of ThG (100 nM) - mediated increases in intracellular Ca
2+ by PABA/NO, purified
homogeneous nitro-aromatic product (MW 622 Da), or PABA. C) Dose-dependent increases in Ca
2+ following PABA/NO (Control) or PABA were
measured; in the presence of the intracellular Ca
2+ chelator BAPTA-AM (5 mM); or in the presence of the extracellular Ca
2+ chelator, EGTA (5 mM, long
dashedline). The fluorescence measurements were recalculated as actual intracellular Ca
2+ concentrations (see Materials and Methods). D) Kinetics of
intracellular NO (left Y-axis) and Ca
2+ (right Y-axis, solid line) generation after PABA/NO (15 mM) addition. Data are the average representative traces (A
and D) or mean 6 SE (B, C) for 3 independent experiments.
doi:10.1371/journal.pone.0014151.g002
Nitric Oxide/Ca
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involved in this inhibition. After incubating cells with 25 mM
PABA/NO for 30 min, co-staining of eNOS with the S-
glutathionylated protein antibodies in HL60 cells was detected
(Fig. 6, panel A). The expression of eNOS was substantially greater
in HDMVEC than in HL60 cells. Fig. 6 shows the effects of
PABA/NO on the S-glutathionylation of monomeric (,137 kDa)
and the higher molecular weight band (,230 kDa) of eNOS
under non-reducing conditions. The reduction of the disulfide
bonds with TCEP caused the high molecular weight band to
disappear (data not shown), suggesting that it could represent
disulfide bond formation between denatured monomers during
sample boiling in SDS. PABA/NO treatment of HDMVEC
resulted in a decrease of the high molecular weight band and in a
consequent increase of eNOS monomer, perhaps as a conse-
quence of sulfhydryl modification through S-nitrosylation or S-
glutathionylation. In HDMVEC, the eNOS monomer was
immunoprecipitated with the anti-glutathionylated protein anti-
body and there was a quantitative increase following PABA/NO
treatment (Fig. 6, panel C), a result consistent with our hypothesis.
Figure 3. The effect of eNOS suppression in HL60 cells after siRNA transfection. A) Fluorescent and DIC images of cells before (upper
panels) and after (lower panels) transfection with FITC-labeled siRNA. B) Viability of mock (black column) and eNOS siRNA transfected cells (white
column) detected by trypan blue exclusion. C) Immunoblot analysis of cell lysates (,100 mg of total protein/lane) compared to standard (STD,
Cayman) with eNOS detection. D) Immunoblot (panel C) quantification. E) Immunoblot analysis of eNOS in HL60 cells (1) and in HDMVEC (2) lysates
(,20 mg of total protein/lane); Data in B) and D) represent mean 6 SE of 3 independent experiments. Loading controls with GAPDH detection on the
same blot are presented.
doi:10.1371/journal.pone.0014151.g003
Nitric Oxide/Ca
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glutathionylation of multiple proteins in HL60 cells [8,25]. Thus,
we analyzed the total cellular protein sulfhydryls at steady state
and following drug treatment in both HL60 and HDMVEC
(Fig. 6, panel B). PABA/NO caused a ,6% decrease in cytosolic
protein sulhydryls in HL60 and ,15% decrease in HDMVEC
versus the controls. The latter indicates sulfhydryl modification
upon PABA/NO treatment. Basal protein sulfhydryl levels in
HL60 cells were higher than in HDMVEC (inversely proportional
to eNOS level in these cells). The ThG effect was not statistically
different from that of PABA/NO. The addition of TCEP resulted
in disappearance of all bands, indicating IP specificity for S-
glutathionylated proteins.
Plasma membrane associated effects of PABA/NO
treatment in HL60 cells
PABA/NO is poorly soluble and relatively unstable in water.
This may result in decomposition-mediated NO generation. NO is
easily diffusible through plasma membranes and it is difficult to
discriminate between processes of intracellular or extracellular
generation. HL60 cell surface protein sulfhydryl modifications
were monitored after PABA/NO or ThG using TG-1. A dose-
dependent but saturable decrease of cell surface sulfhydryls was
detected after the PABA/NO addition (Fig. 7, panel A).
Subsequent TCEP addition to PABA/NO treated HL60 cells
did not reverse the drug-mediated sulfhydryl modifications (data
not shown) indicating an absence of disulfide bonds and perhaps,
Figure 4. eNOS depletion alters basal and PABA/NO mediated NO generation and cell growth. A) HL60 and TReNOS
2/2 cells labeled
with DAF-FM to measure total basal NO levels. B). NO generation in HL60 cells following PABA/NO, PABA, or ThG titration. C) Kinetics of intracellular
Ca
2+ increase in TReNOS
2/2 after PABA/NO (25 mM) or ThG (20 nM) addition. D) Growth curves for HL60 and TReNOS
2/2 cells. Data represent: mean
6 SE (panels A and B) for 3 independent experiments; representative traces of 3 independent experiments (panel C); and average 6 variance for 2
independent experiments (panel D).
doi:10.1371/journal.pone.0014151.g004
Nitric Oxide/Ca
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contrast, neither PABA nor ThG directly yields NO and neither
affected the surface protein-thiol status (Fig.7, panel A).
NO synthesis and calcium cycling are known to modulate
membrane polarization. We evaluated the plasma membrane
potential (Vm) in HL60 cells following PABA/NO or ThG
treatment. Immediate hyperpolarization of the plasma membrane
occurred after either PABA/NO or ThG treatment with a
subsequent relatively slow (,200–250 sec) depolarization. The
effect for PABA/NO was ,10 times greater when compared to
ThG and showed a slower rate of depolarization, suggesting a
multistep process (Fig. 7, panel C). PABA addition resulted in
negligible effects on plasma membrane potential indicating the
involvement of the NO-generating capacity of PABA/NO, its
initiation of Ca
2+ fluxes, and secondary eNOS-mediated intracel-
lular NO production. Our data also show that addition of PABA
(fluorescent Ex.,283 nm, Em. ,332 nm, 25 mM) to HL60 cells
did not initiate any changes in its fluorescence (Fig. 7, panel B). In
addition, treatment of HL60 cells with 25 mM of DETA/NO or
DEA NONO-ate did not induce Ca
2+ fluxes (Fig. 7, panel D)
regardless of its capacity to generate NO (Fig. 1, panel A). These
results indicate that NO itself does not directly mediate Ca
2+ fluxes
in HL60 cells.
PABA/NO metabolism in HL60 cells
Fig. 8 shows that either under in vitro or in vivo conditions, the
primary metabolite of PABA/NO has a single HPLC peak with a
retention time of 16.84 min. This was characterized further by
spiking the sample with purified from in vitro reaction metabolite,
showing co-mobility of the mixture (Fig. 8 panel C). The
molecular mass of this purified product was assessed through
ESI MS analysis and m/z was found to be 623.8 (.97%
homogeneity, Fig. 8, panel D, left panel). Incubation of HL60 cells
with this purified product resulted in its detection in cytosole
(Fig. 8, panel D, right panel). Although the data shown are from
the cytosolic fraction of HL60 cells, approximately 90% of this
glutathione-conjugated metabolite was found in the pellet fraction,
implying a possible association with organelles.
Discussion
The focus of our present study was to investigate the influence of
PABA/NO on the dynamics of intracellular Ca
2+ and NO
homeostasis. The data support a role for eNOS in potentiating the
direct nitrosative stress caused by PABA/NO decomposition. The
effects of PABA/NO on the kinetics of the intracellular Ca
2+
increases are similar to those for ThG and imply a possible shared
target such as SERCA, responsible for release of Ca
2+ from
intracellular stores. This concept is supported by our data
suggesting that mobilization of cytosolic Ca
2+ is independent of
extracellular Ca
2+. These data and the bell-shaped kinetics suggest
that PABA/NO and ThG may have similar site(s) of action but
with distinct affinities. A direct comparison of ThG and PABA/
Figure 5. Inhibition of calmodulin diminishes NO generation following PABA/NO treatment. A) Basal NO levels in HL60 and TReNOS
2/2
cells before and after incubation with 50 nM of the specific CaM-inhibitor W-7. B) Kinetics of NO generation in HL60, HL60 cells after preincubation
(30 min) with 50 nM of W-7, and in TReNOS
2/2 cells following PABA/NO (25 mM) addition. Data represent: mean 6 SE (panel A) and representative
traces (panel B) of 3 independent experiments.
doi:10.1371/journal.pone.0014151.g005
Table 1. Estimated basal and PABA/NO-induced intracellular
NO levels.
Cells N
DAF-FM emission,
counts/sec [NO], nM
HUVEC 5 1.06260.1164 20.0
HDMVEC 5 0.73860.1604 14.063.0
HDVEC+PABA/NO (5 mM) 5 9.59460.9124 182.0617.3
HL60 6 0.062460.00525 1.260.1
HL60+PABA/NO (5 mM) 6 0.135460.01175 2.660.2
HL60+PABA/NO (25 mM) 6 0.499260.0487 9.660.3
Data represents mean6SEM for indicated number (N) of experiments.
doi:10.1371/journal.pone.0014151.t001
Nitric Oxide/Ca
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substantially diminishes the effects of ThG with ID50 of ,3 mM.
ThG is a known SERCA antagonist, which causes Ca
2+-influx
from intracellular stores [26]. ONOO
2-activated Ca
2+ uptake into
sarco(endo)plasmic reticulum is mediated by SERCA through its
S-glutathionylation at Cys674 [18,19]. Permanent inactivation of
SERCA by ThG could cause the deleterious effect of uncontrolled
increases in intracellular Ca
2+ through activation of apoptotic
pathways [27]. Nitrosative stress caused by PABA/NO does not
cause high levels of stable cysteine nitrosylation [3], but instead
leads to S-glutathionylation of multiple intracellular proteins [6,8].
Our present data show that these effects are also associated with an
increase of cytosolic Ca
2+, indirectly associated with PABA/NO-
induced nitrosative stress. DETA/NO-mediated and DEA
NONO-ate-mediated NO generation does not initiate Ca
2+ flux,
suggesting that direct NO is not mechanistically linked to the Ca
2+
affect. This implicates the stable nitro-aromatic GSH-conjugate of
PABA/NO as the likely inhibitor of SERCA [7]. Our results
confirm that the kinetics of this reaction in vitro depend on the
presence of the intracellular nucleophile GSH [7]. It is proposed
that intracellular PABA/NO undergoes the same spontaneous or
GST-catalyzed nucleophilic attack by GSH resulting in direct
release of NO. However, the GSH-conjugated-nitro-aromatic
metabolite shown in Fig. 8 is responsible for the indirect effects
documented. Supporting this, our prior studies show that over-
expressing MRP1 in mouse embryo fibroblasts conferred resis-
tance to PABA/NO, suggesting that a toxic glutathione conjugate
is effluxed from the cells [6]. In addition, the EC50 for ThG in
tissue culture was in the range of 90–205 nM [28,29]. Our data
show ThG-mediated increase in NO generation with
EC50,85 nM. This similarity in EC50 is suggestive that
SERCA-mediated intracellular Ca
2+ fluxes are a likely reason
for NO generation by eNOS.
HL60 cells share common progenitor stem cells with endothelial
cells and other leucocytes. While both eNOS and iNOS are
expressed in HL60 cells [30,31], the former is significantly higher
in HDMVEC. Our data show that NO response to the same dose
of PABA/NO was ,14 times higher in HDMVEC as compare to
that in HL60 cells (Fig. 2, panel D). This indicates proportionality
of PABA/NO-derived NO production to eNOS expression. Basal
iNOS levels are stable for at least 72 h in HL60 cells [24]. We
confirmed [31] that HL60 cells do not express NOS1. Depletion of
eNOS (siRNA) or inhibition of eNOS or CaM (L-NAME, W-7)
diminished NO generation and caused growth inhibition.
Figure 6. PABA/NO-mediated S-glutathionylation of eNOS in HL60 and HDMVE cells. A) Control and PABA/NO-treated (25 mM, 30 min)
HL60 cell lysates (,100 mg protein/lane) resolved by non-reducing SDS-PAGE and evaluated by immunoblot with eNOS polyclonal primary
antibodies and PSSG monoclonal primary antibodies and detected simultaneously with both: anti-mouse (red) and anti-rabbit (green) fluorescent
secondary antibodies. B) Fluorescent detection (TG-1) of cytosolic protein sulfhydryls in HDMVE and in HL60 cells before (CTR) and after: PABA/NO
(20 mM, 30 min) or ThG (200 nM, 30 min) addition. C) Immunoprecipitation of eNOS from HDMVEC with S-glutathionylated protein antibody. The
blot was developed with the eNOS antibodies. Lanes are: 1- control HDMVEC lysate; 2- PABA/NO-treated (20 mM, 30 min) cell lysate; 3- IP of control
cell lysate; 4- IP of PABA/NO-treated cell lysate; 5 -IP of PABA/NO-treated cell lysate after TCEP treatment. Arrows indicate low and high molecular
weight eNOS bands. Loading controls are actin immunostaining. Data are: representative blots (panels A, C) and mean 6 SD of 3 independent
experiments, statistical significance p#0.001.
doi:10.1371/journal.pone.0014151.g006
Nitric Oxide/Ca
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and eNOS-mediated acute NO burst (,10-fold increase) in HL60
cells. Similar but more pronounced PABA/NO effects were
detected in HDMVEC.
PABA/NO treatment caused plasma membrane (Vm) hyper-
polarization/depolarization without an extracellular Ca
2+ influx.
HL60 cells express plasma membrane-associated NADPH oxidase
[32] that can generate a superoxide radical (O2
-). NO is ,3 times
more effective scavenger of O2
2 than SOD [33] and this reaction
produces ONOO
2, an effective nitrosylating agent. The extra-
cellular PABA/NO effect may be associated with S-nitrosylation of
K
+/Na
+ channels, which corresponds to the cell surface cysteine
modification presented in our present study. Similar observations
of NO effects on Vm in P388D.1 macrophage-like cells through
K
+ fluxes were reported earlier [34]. Additionally, ThG effects on
Vm were kinetically similar, but ,10 times lower than those for
PABA/NO, indicating a role for extracellular NO. By contrast,
PABA did not induce any cell surface effects, confirming the
Figure 7. PABA/NO effect on surface protein thiols and plasma trans-membrane potential in HL60 cells and controls for PABA,
DETA/NO and DEA NONOate effects. A) Fluorescent detection (TG-1) of dose-dependent HL60 surface protein sulfhydryls level after PABA/NO,
PABA and ThG addition. B). PABA (50 mM) addition to HL60 cells (with or without extracellular Ca
2+) did not initiate generation of fluorescent
metabolite (MW 622). C) Plasma trans-membrane potential (Vm) recorded as Bis-Oxanol emission at 520 nm after addition of 20 nM ThG, 25 mM PABA
or 25 mM PABA/NO in HL60 cells. D) DETA/NO and DEA NONOate (25 mM) addition to HL60 cells did not initiate Ca
2+ fluxes. Data represent: mean 6
SE (panel A), representative traces averaged and smoothed with Sigma Plot 10.0 software (panel C), and original representative traces (panel B and D)
of 3 independent experiments.
doi:10.1371/journal.pone.0014151.g007
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plasma membrane depolarization was diminished by eNOS
depletion (data not shown). All these data indicate, not
unexpectedly, that PABA/NO causes cell surface, as well as
intracellular effects.
The active form of eNOS is a homodimer with zinc ions
tetrahedrally coordinated to two pairs of symmetrical cysteines
(Cys94 and Cys99 in each monomer [35,36]). These cysteine
residues are in a basic environment and as a consequence, have a
low pK and may be subject to S-glutathionylation. It has been
shown that nitrosylation of some of these cysteines results in
dissociation of homodimers into inactive monomers [37]. eNOS is
palmitoylated and therefore attached to an inner leaf of the plasma
membrane. Thus, its activation results in an NO burst close to the
plasma membrane. As well as an NADPH oxidase, there is a
chloride ion channel-3 (CIC-3) [38] in the plasma membrane of
HL60 cells. The Ca
2+ fluxes could activate NADPH oxidase [39]
and superoxide-radical generated outside the cells could influx
through CIC-3 channels [40]. When spatially close, the eNOS and
CIC-3 channels may generate ONOO
2, which together with
excess GSH can induce eNOS S-glutathionylation. The effect of
PABA/NO on Ca
2+/NO homeostasis in HL60 cells starts as an
extracellular NO-mediated surface protein-thiol modification.
Intracellular PABA/NO, spontaneously or under GSTP-catalysis,
generates NO and the stable nitro-aromatic GSH-conjugate
(PABA-SG) according to the scheme:
PABA=NOzGSH? PABA=NO-SG ½  ?PABA-SGz2NOzHNMe2:
Meisenheimercomplex
In our present study we showed that this metabolite inhibits
SERCA, most likely, at the same site as ThG initiating an
intracellular Ca
2+ increase, activating CaM and consequently
eNOS with the resultant NO burst. We hypothesize that PABA/
NO causes intracellular NO levels to rise above a certain threshold
Figure 8. Reaction of PABA/NO with GSH in vitro and in HL60 cells. A) Scheme of nitro-aromatic PABA/NO-GSH adduct (MW 622 Da)
generation. B) HPLC analysis of PABA/NO-GSH reaction in vitro and detection of PABA standard under the same conditions. C) HPLC analysis of HL60
lysate after incubation with 50 mM PABA/NO (1) and after ‘‘spike’’ with the purified nitro-aromatic adduct (MW 622 Da, 2). D) ESI MS analysis of
purified from in vitro reaction nitro-aromatic PABA/NO-GSH adduct (m/z 623.8, left panel) and HL60 cells lysate after their incubation with purified
nitro-aromatic adduct (m/z 623.8) product (right panel, indicated with asterisk).
doi:10.1371/journal.pone.0014151.g008
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nitrosylation and S-glutathionylation. Indeed, there is evidence to
suggest that two distinct pools of S-nitrosylated proteins exist, one
that GSH stable and another that is GSH labile and subject to
rapid conversion to a S-glutathionylated product [41,42]. Both of
these protein post-translational modifications have a role in signal
transduction [43]. There are two mechanisms of NO-mediated
protein S-glutathionylation: through a GSNO (activated thiol)
formation and its consequent reaction with protein-thiol [44] or
through an intermediate protein-thiol nitrosylation (activated
protein-thiol: analogue of sulfenic acid) and its consequent reaction
with the most abundant intracellular redox buffer, GSH [43]. The
exact mechanism of eNOS modification is unknown but in vivo
experiments have shown that eNOS activation in aortas and iNOS
transgenetic expression in mouse heart both result in NO-induced
protein S-glutathionylation [45]. Our present data are compatible
with the interpretation that PABA/NO-mediated eNOS activa-
tion results in its S-glutathionylation in HL60 and HDMVE cells.
This dynamic modification may serve to physiologically down
regulate eNOS by NO under normal conditions [46]. Conversely,
eNOS deglutathionylation via thioredoxin/thioredoxin reductase,
glutaredoxin/glutaredoxin reductase [47,48] or sulfiredoxin
[14,49], results in eNOS up-regulation, maintaining physiological
NO levels. Under normal physiological conditions the NO
increase might be controlled by S-nitrosylation/glutathionylation
of eNOS as an immediate response or by similar modification/
activation of SERCA in steady-state regulation (Fig. 9). Alterna-
tively, in tumor cells with high levels of GSTP expression, the rate
of PABA/NO-mediated NO increase could be substantially faster,
outcompeting eNOS down-regulation through S-nitrosylation/
glutathionylation and this could contribute to the cytotoxicity of
the drug.
Conclusions
Overall, the data are consistent with the model scheme in Fig. 9.
The diazeniumdiolate has membrane effects that are attributable
to NO release extracellularly or at the level of the plasma
membrane. Intracellulary, the major nitroaromatic glutathione
conjugate, primarily localized to the non-soluble cell fraction, can
inhibit SERCA, increasing intracellular Ca
2+ release and having
an effect upon NOS that stimulates more NO release. NOS is
subject to auto-regulation through S-glutathionylation. Thus, the
drug has both a direct and indirect impact upon NO homeostasis
and generates a chain of events that can alter cell-signaling
pathways in a complex and inter-related manner.
Materials and Methods
Chemicals
Fura-2-AM (Acetoxymethyl 2-[5-[bis[(acetoxymethoxy-oxo-
methyl)methyl]amino]-4-[2-[2-[bis[(acetoxymethoxy-oxo-methyl)-
methyl]amino]-5-methyl-phenoxy]ethoxy]benzofuran- 2-yl]oxa-
zole-5-carboxylate), Fluo-3-AM (1-[amino-5-(2,7-dichloro-6-
acetomethoxy-3-oxo-3H-xanthen-9-yl)phenoxy]-2-(29-amino-59-
methylphenoxy)ethane-N,N,N9,N9-tetraacetic acid, penta-acetoxy-
methyl ester), DAF-FM-DA (3-amino, 4-aminomethyl-29,79-
difluorofluorescein diacetate), BAPTA-AM (1,2-bis-(o-Aminophe-
noxy)-ethane-N,N,N9,N9-tetraacetic acid, tetraacetoxymethyl es-
ter), JC-9 (DiNOC1(3), 3,39-dimethyl-a-naphthoxacarbocyanine
iodide) and Bis-Oxonol (bis-(1,3-dibutylbarbituric acid)trimethine
oxonol (DiBAC4(3)) were purchased from Invitrogen (Carlsbad,
CA). ThioGloH 1 (TG1, 3H-naphthol [2,1-b] pyran-s-carboxylic
Acid; 10-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-9-methoxy-3-
oxo-, methyl Ester) and Thapsigargin (ThG) were purchased from
Calbiochem (San Diego, CA). PABA (4-aminobenzoic acid
sodium salt), TCEP (tris(2-carboxyethyl)phosphine), W-7 (N-(6-
aminohexyl)-5-chloro-1-naphthalenesulphonamide), 2,29-(Hydro-
xynitrosohydrazono)bis-ethanimine (DETA/NO), and EGTA
were purchased from Sigma (St. Louis, MO). L-NAME (N
v-
nitro-L-arginine methyl ester) and DEA NONO-ate (Diethylam-
monium (Z)-1-(N,N-diethylamino)diazen-1-ium-1,2-diolate) were
purchased from Cayman Chemical Company (Ann Arbor, MI).
Figure 9. Scheme of PABA/NO effects on Ca
2+/NO homeostasis in HL60 cells. PABA/NO effects start as extracellular NO-mediated (from
spontaneous decomposition) surface protein-thiol modifications. Intracellular PABA/NO spontaneously (or under GSTP-catalysis) generates NO and
stable nitro-aromatic compound(s) (PABA-SG). This can inhibit SERCA initiating a release of Ca
2+ from the sarcoplasmic (endoplasmic) reticulum. The
latter activates CaM and, consequently eNOS producing an NO burst. Increases of NO above threshold levels result in eNOS inhibition through its S-
nitrosylation/glutathionylation. Once NO levels start to decline, spontaneous or catalyzed deglutathionylation of eNOS results in its reactivation to
maintain steady state NO levels.
doi:10.1371/journal.pone.0014151.g009
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Section, Laboratory of Comparative Carcinogenesis, NCI at
Frederick (Maryland).
Tissue culture
The human promyelocytic leukemia cell line HL60 was
obtained from the American Type Culture Collection (ATCC;
Rockville, MD) and maintained in RPMI-1640 with 10% heat-
inactivated fetal calf serum (FCS) in a 5% CO2 atmosphere at
37uC. Primary culture of human dermal microvascular endothelial
cells (HDMEC, [50]) and of human umbilical vein endothelial
cells (HUVEC) were provided by Drs. S. Lenna and M.
Markiewicz (both from the Department of Medicine, Division of
Rheumatology of the Medical University of South Carolina). Cell
number and viability were determined by trypan blue exclusion
using Cellometer
TM Auto T4 (Nexcelom, Biosciences, Lawrence,
MA). Micoplasma was not detected in our cell cultures.
Calcium labeling
Suspensions of HL60, TReNOS
2/2 cells (1.0610
6cells/ml) and
HDMVEC (,90% confluence on Aclar plastic slides [51]) were
incubated with 5 mM Fura-2-AM or Fluo-3-AM for 1 hour in
complete media at 37uC. Labeled cells were washed 3 times with
PBS, containing 100 mM CaCl2 or 4 mM EGTA, and used for
experiments. To study the effect of chelating intracellular Ca
2+,
cells were incubated with 5 mM BAPTA-AM for 30 min before
the addition of Fluo-3, and after 45 min of incubation were
washed with PBS, containing 100 mM CaCl2 or 4 mM EGTA.
PABA/NO was added to the specified final concentration of the
drug (to avoid DMSO effects, the added volume never exceeded
5 ml). Viability of the intact, fluorescent-labeled control and
PABA/NO-treated cells was measured for each experiment.
Nitric oxide labeling
Suspensions of HL60, TReNOS
2/2 cells (1.0610
6cells/ml) and
HDMVEC (HUVEC) (,90% confluence on Aclar plastic slides
[51]) were incubated with 5 mM of DAF-FM-DA for 1 hour in
complete media at 37uC. The labeled cells were washed 3 times
with PBS, containing 100 mM CaCl2 or 4 mM EGTA.
Kinetics of Calcium and NO
The dynamics of intracellular Ca
2+ and NO changes were
measured using a Modulus
TM Microplate Multimode Reader
(Turner BioSystems, Sunnyvale, CA) with a ‘‘Blue’’ optical kit
(Ex=490 nm, Em=510–570 nm) and a standard kinetics mode.
The measurements were performed at room temperature in 96-
well Fluotrac 200 black microplates (VWR, Greiner Bio-One
North America, Inc. Monroe, NC). The starting point for the
kinetic experiments began ,2 min after the addition of PABA/
NO (e.g. the time necessary for the addition of drug to all wells).
Precise kinetic experiments were performed with the use of PTI
QM-8 (PTI Inc., Birmingham, NJ), Hitachi F-2500 (Hitachi, Japan)
and PTI QM-4 (PTI Inc.) spectrofluorometers and time-based
fluorescence detection (resolution 0.1 sec). These experiments were
performed in a 10610640 mm quartz cuvette under permanent
stirring and temperature control. In these experiments, fluorescence
was recorded for 100 sec prior and for indicated time after PABA/
NO, DEA NONOate, DETA/NO, or ThG addition. Fresh
prepared stock solutions of PABA/NO (100 mM in DMSO), DEA
NONOate (100 mM in 0.01N NaOH), DETA/NO (100 mM in
10 mM PB, pH=7.4), ThG (100 mM in DMSO) and PABA
(100 mM in water, pH adjusted to 7.0) were used. All fluorescent
measurements were corrected using the following controls: fluores-
cenceof unlabeled cells,fluorescencechangesinlabeled cells without
any addition of effectors and the effect of the addition of
corresponding solvents to the fluorescence of labeled and intact cells.
Total intracellular NO level in HDMVE and HL60 cells
In order to calculate intracellular NO concentration in
HDMVEC, we used HUVEC as a standard. Both types of cells
were grown on Aclar (Electron Microscopy Sciences, Hatfield, PA)
plastic slides (12620 mm) to ,90% confluence under standard
conditions in 30 mm Petry dishes. Cells were exposed to 5 mMo f
DAF-FM-DA in complete media for 1 h at 37uC and washed
three times with PBS - to eliminate extracellular dye. A slide with
the labeled cells was placed in a quartz cuvette (10610640 mm,
containing 2.5 ml of PBS with 5 mM EGTA, pH=7.4 at 37uC)
under a 45u angle to the excitation beam, and the emission at
515 nm (excitation at 488 nm) was recorded for ,5 min. After the
measurement, the cells on the slide were trypsinized and counted
using Cellometer
TM Auto T4. The total slide area was 240 mm
2
and the area from which fluorescence was acquired was
,38.4 mm
2 (for excitation and emission slits 2 and 4 nm,
respectively). Thus the number of cells from which fluorescence
was acquired, was (NFL=N*0.9*(34.8/240)), where N – corre-
sponds to the total number of cells, and 0.9 corresponds to the
90% confluence). The slides with DAF-FM-labeled HUVE and
HDMVE cells were imaged under fluorescent microscope to
confirm localization of fluorescence only inside cells (the level of
labeling was .90%, data not shown).
For HL60 cells (suspension) labeling with DAF-FM-DA was the
same as for the adherent cells. After washing them three times with
PBS, 2 ml of labeled HL60 cells (1.0*10
6 cells/ml) in PBS
(100 mM of CaCl2 or 5 mM EGTA, pH=7.4, 37uC) was placed in
a quartz cuvette and the fluorescence of DAF-FM was recorded
for 5 min. The labeled HL60 cells were also imaged under
fluorescent microscope to show that fluorescence was localized
inside the cells (the level of labeling was .90%, data not shown).
The actual volume of the rectangular cuboid (under our
experimental conditions) from which fluorescence was acquired
was 64 mm
3. The number of cells in this volume was 64*10
3. The
fluorescence of HUVEC or HDMVEC (5 slides of each) and
HL60 cells (6 independent experiments) were averaged and
normalized for cell number. The results of this analysis are
presented in Table 1. The resting NO level in HUVEC was
reported as 20 nM [52] and corresponds to a certain DAF-FM
fluorescence per cell (Table 1). Thus the NO levels in HDMVE
and HL60 cells are proportional to DAF-FM fluorescence per cell
and could be calculated (Table 1).
ThG, PABA/NO, and nitroaromatic compound (MW
,622 Da) competition analysis
The Fluo-3-labeled (5 mM) HL60 cells (1.0*10
6 cells/ml) were
incubated with the indicated amount of PABA/NO or purified
homogeneous nitroaromatic compound (MW ,622 Da) for
20 min in PBS complemented with either 100 mM of CaCl2 or
5 mM of EGTA in a quartz cuvette at 37uC under constant
stirring. After recording the background emission for 1 min,
100 nM (final concentration) of ThG was added to cell suspension
and fluorescence was recorded for ,5 min. The resulting kinetic
curves were integrated using standard PTI software and
normalized for ThG effect without the PABA/NO addition.
Plasma membrane potential measurements
Suspension of HL60 cells (1.0610
6 cells/ml) in PBS with
100 mM CaCl2 (pH=7.4) was incubated under constant stirring in
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DMSO was added to cell suspension (final concentration 5 mM)
and the kinetics of emission at 520 nm (Ex=488 nm) were
monitored before and after PABA/NO (ThG, PABA, DETA/
NO) addition with a resolution of 0.1 sec for 5 min. Represen-
tative trace of three independent experiments was averaged and
smoothed using standard SigmaPlot 10.0 (Systat Software Inc.,
San Jose, CA) software.
Analysis of intracellular reduced protein thiols
Low molecular weight compounds were removed from the cell
lysate using size-exclusion chromatography with a Bio-Spin 6
column (BioRad, Hercules, CA). After measuring protein
concentration (Bradford, BioRad, Hercules, CA), the cell lysate
was diluted 1:100 with 20 mM sodium phosphate, pH=7.4 in a
quartz cuvette under constant stirring at 37uC. After the addition
of TG-1 (5 mM), the kinetics of fluorescence at 513 nm (excitation
at 379 nm) were recorded for ,4 min. To measure surface thiol
status in HL60 cells, TG-1 (final concentration 5 mM) was added
to cell suspensions (1.0*10
6 cells/ml) in PBS at 4uC under constant
stirring, and kinetics of emission was recorded. The saturation
fluorescence values of TG-1 treated cell lysates were normalized
for protein content and cell surface thiol contents were normalized
for the cell number and averaged using standard SigmaPlot 10.0
software (Systat Software Inc., San Jose, CA). At the end of each
experiment, 1 mM GSH was added to the sample to ensure that
the saturation of fluorescence was not caused by TG-1 content.
siRNA-mediated inhibition of eNOS expression in HL60
cells
NOS3 siRNA(h) was purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). HL60 cells were transfected with NOS3
siRNA(h) to generate TReNOS
2/2 cells according to the
manufacturer’s recommendation. Approximately 80% transfec-
tion efficiency was determined by flow cytometry with the use of
FITC-labeled NOS3 siRNA(h) and confirmed by fluorescent
microscopy (Nikon eclipse E800, Nikon Instr., Inc, Lewisville, TX
with Nikon DS-U1 software v. 5.03, Photometrics, Tucson, AZ).
Immunoprecipitation
Monoclonal antibodies against S-glutationylated proteins (Viro-
gen, Watertown, MA) were conjugated with CNBr-activated
sepharose (GE Healthcare) according to the manufacturer’s
recommendations. The yield of conjugation was controlled by
measuring absorbency of antibody solution at 280/220 nm before
and after conjugation and was ,60–80%. After passing through a
BioSpin-6 (BioRad) microcolumn (to eliminate low molecular
weight thiols) HDMVEC lysates (,200 mg of total protein) were
incubated with a sepharose-conjugated antibody for 4–6 hours at
room temperature under constant agitation. The sepharose
immunoprecipitate was separated by centrifugation (16.0610
3 g,
5 min). After washing with PBS (3 times), the precipitated proteins
were separated from the sepharose-conjugated antibody by
acidification with glycine buffer (0.5 M, pH=2.1) and collected
by centrifugation (16.0610
3 g, 15 min, 4uC). The supernatants
were concentrated using a CentriVap concentrator (LABCONCO
Co, Kansas City, MO) and used for SDS PAGE and immunoblot
analysis.
Immunoblot analysis
HL60, TReNOS
2/2 and HDMVE cells were lysed and cell
homogenates were separated by centrifugation. Lysate protein was
electrophoretically resolved by SDS-PAGE (8–10% Tris-Gly gel,
1 mm), and transferred to PVDF membranes (BioRad, Hercules,
CA). Non-specific binding was reduced by incubating the
membrane in a blocking buffer (20 mM Tris-HCl, pH 7.5,
150 mM NaCl, 0.1% Tween 20, 1 mM protease inhibitors,
5 mM NaF, and 1 mM Na3VO4) containing 10% non-fat dried
milk for 1 hour. Endothelial NOS was immunostained with anti-
NOS3 polyclonal antibody (1:250), (C-20: Santa Cruz Biotech-
nology, Inc., Santa Cruz, CA) and detected with an HRP-
conjugated secondary antibody and ECL (GE Healthcare Bio-
Sciences Corp., Piscataway, NJ). eNOS electrophoresis standard
(Cayman Chemical Co., Ann Arbor, MI) was used as a positive
control for detection. The blots were scanned and visualized with a
ChemiDoc system (BioRad). The relative intensity of bands was
evaluated using Quantity One software (ver. 4.5.2; Bio-Rad) and
plotted as arbitrary units (a.u.).
An infrared excited dual color (red and green) fluorescent
imaging system (Odyssey LI-COR, NE) was used to detect S-
glutathionylation of eNOS (eNOS-SSG) in HL60 cells after
treatment with the indicated amounts of PABA/NO. Proteins
from cell lysates were resolved electrophoretically and transferred
to the PVDF membranes, as described above. Membranes were
treated with the proprietary blocking buffer (LI-COR, NE) and
incubated with both polyclonal anti-NOS3 and monoclonal anti-
glutathionylated protein antibodies (1:1,000 dilution, Virogen,
Watertown, MA), as described above. After a 36 washing with
PBS, an immunoblot was developed simultaneously with anti-
rabbit IRDyeH800CW (green) and anti-mouse IRDyeH680 (red)
secondary antibodies (1:1,000 dilution, both from LI-COR, NE),
as per manufacturer’s protocol. Finally, immunoblots were imaged
with an Odyssey imaging system (LI-COR) and quantified with
standard software (LI-COR, NE).
HPLC analysis
HPLC analysis was performed using 1525 binary pump, 2487
UV detector and 717plus Autosampler and Sunfire
TM C18, 5 mm,
4.66150 mm column (All from Waters, Milford, MA) with mobile
phase ACN-0.1% formic acid (flow rate 1.0 ml/min) and
detection at 315 nm. The mobile phase consisted of 25% ACN
and 75%, 0.1% formic acid for 5 min, followed by a linear
gradient to 75% ACN and 25% of 0.1% formic acid for the next
10 min. The PABA/NO (25 mM) reaction with GSH (2.0 mM) in
20 mM PB (pH=7.4) was performed at room temperature and
after incubation for the indicated time the samples were analyzed
by HPLC. Absorbance and fluorescence spectra of the reaction
mixture were also monitored. The purified PABA/NO metabolite
(MW 622 Da) under our experimental conditions had a retention
time of 16.849 min, absorbance spectra with maxima at ,222 nm
(compatible with specific absorbance of peptide bond) and 315 nm
(corresponding with reported earlier specific absorbance for
PABA/NO), and fluorescence spectra with emission maximum
at 350 nm (excitation at 290 nm). ESI MS analysis of this purified
product show singular most abundant (,90% homogeneity) peak
with M/Z=623.8. To monitor metabolic conversion of PABA/
NO we incubated HL60 cells (10.0*10
6) with PABA/NO (50 mM)
for 30 min at 37uC. Incubated cells were washed 3 times with PBS
and lysed with standard cell extraction buffer (Invitrogen) with
addition of a standard mixture of proteinase inhibitors (Sigma).
After incubation of the cells with lysis buffer for 25 min at 4uC
with periodic vortexing, samples were centrifuged at 16.1*10
3 g
for 5 min. The supernatant was collected and after addition of
10% (final concentration) of TCA and was again centrifuged at
16.2*10
3 g for 15 min. The final supernatant was used for HPLC
analysis. After primary HPLC analysis the peak with retention
time of 16.84 min was identified. The addition of purified from in
Nitric Oxide/Ca
2+ Homeostasis
PLoS ONE | www.plosone.org 13 November 2010 | Volume 5 | Issue 11 | e14151vitro reaction mixture PABA/NO metabolite (MW 622 Da) to this
sample of cell lysate (‘‘spike’’) resulted in specific ,2-fold increase
of the peak at 16.84 min. Such data are consistent with the
intracellular generation of this PABA/NO metabolite (MW
622 Da). Incubation of HL60 cells with purified nitro-aromatic
compound (MW 622 Da, 15 mM, 35 min) resulted in its ESI MS
detection in cell lysate after TCA precipitation. All HPLC data
were processed using MPower software (built 2154, Waters Corp.).
Mass spectrometric analysis
Samples were analyzed via liquid chromatography (LC)-
electrospray ionization (ESI) -tandem mass spectrometry (MS/
MS) on a linear ion trap mass spectrometer (LTQ, Thermo
Finnigan) coupled to an LC Packings nano LC system. A
75micron C-18 reversed phase LC column (Microtech Scientific)
was utilized with a 30 minute gradient from 2% acetonitrile, 0.2%
formic acid to 60% acetonitrile, 0.2% formic acid. Data
Dependant Analysis was utilized on the LTQ to perform MS/
MS on all ions above an ion count of 1000. Dynamic Exclusion
was set to exclude ions from MSMS selection for 3 minutes after
being selected 2 times in a 30 second window.
Statistical analysis of experimental data
All experimental data were statistically evaluated using Sigma-
Stat 3.5 (Systat Software Inc., San Jose, CA) and represented as a
mean6SEM (SD). The ANOVA was used to evaluate the
relevance of a difference between control and treatment groups.
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